08/14/2024 | Press release | Distributed by Public on 08/14/2024 19:01
AN2 Therapeutics, Inc.
|
(Name of Issuer)
|
Common Stock, $0.00001 par value per share
|
(Title of Class of Securities)
|
037326105
|
(CUSIP Number)
|
August 14, 2024
|
(Date of Event Which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS
|
|||
BML Investment Partners, L.P.
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|||
(a)☐
|
||||
(b)☒
|
||||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|||
Delaware
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
||
0
|
||||
6
|
SHARED VOTING POWER
|
|||
5,749,432
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|||
0
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|||
5,749,432
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
5,749,432
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|||
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|||
19.3
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|||
PN
|
||||
Item 1(a). | Name of Issuer: |
Item 1(b). | Address of Issuer's Principal Executive Offices: |
Item 2(a). | Name of Person Filing: |
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
Item 2(c). | Citizenship: |
Item 2(d). | Title of Class of Securities: |
Item 2(e). | CUSIP Number: |
Item 3. | If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or |
|
(a) | ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); |
|
(b) | ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); |
|
(c) | ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); |
|
(d) | ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
|
(e) | ☐ Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); |
|
(f) | ☐ Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); |
|
(g) | ☐ Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); |
|
(h) | ☐ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
(i) | ☐ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
|
(j) | ☐ A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); |
|
(k) | ☐ Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . |
Item 4. | Ownership. |
|
(a) | Amount beneficially owned:5,749,432 |
|
(b) |
Percent of class: 19.3 |
|
(c) | Number of shares as to which the person has: |
|
(i) | Sole power to vote or to direct the vote: 0 |
|
(ii) | Shared power to vote or to direct the vote: 5,749,432 |
(iii) |
Sole power to dispose or to direct the disposition of: 0 |
(iv) | Shared power to dispose or to direct the disposition of: 5,749,432 |
Item 5. | Ownership of Five Percent or Less of a Class. |
Item 6. | Ownership of More Than Five Percent on Behalf of Another Person. |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. |
Item 8. | Identification and Classification of Members of the Group. |
Item 9. | Notice of Dissolution of Group. |
Item 10.
|
Certification.
|
COMPANY NAME
|
||
|
||
By:
|
/s/ Braden M Leonard
|
|
Name: Braden M Leonard
|
||
Title: Managing Member
|